CMS: Expect MIPS eligibility notices in next month

Clinicians should soon be receiving notices on whether they’ll be required to participate in the new Merit-based Incentive Payment System (MIPS), CMS said in a notice issued on April 25.

MIPS is one of the two new payment tracks established by the Medicare Access and CHIP Reauthorization Act (MACRA). After concerns about rushing the transition to a new payment system, CMS allowed “pick your pace” options for MIPS reporting in 2017.

With nearly of a third of the year having passed, however, providers haven’t received notices on whether they’re qualified for MIPS. The Medical Group Management Association wrote to CMS in March asking for a quick release on the overdue eligibility information, including “low volume threshold exemptions, status as hospital-based or non-patient-facing, as well as approved lists of registry vendors.”

It appears CMS is now addressing those concerns, with MIPS eligibility letters being sent out over the next month.

“In late April through May, practices will get a letter from the Medicare Administrative Contractor that processes Medicare Part B claims. This letter will tell the participation status of each MIPS clinician associated with the Taxpayer Identification Number or TIN in a practice,” the CMS notice read.

Clinicians will be told they should participate in MIPS for the 2017 transition year if they bill more than $30,000 in Medicare Part B allowed charges annually and provide care for more than 100 Part B-enrolled Medicare beneficiaries per year.

As discussed at the American College of Healthcare Executives (ACHE) Congress in Chicago, this low-volume threshold may affect healthcare leaders’ decisions to have clinicians report individually or as a group in MIPS. The exemption is judged at reporting entity level, and clinicians can’t pick and choose which MIPS measures they report as a group.

“You get to four-person group, you almost automatically go over the threshold,” said Martie Ross, principal at consultant company Pershing Yoakley and Associates (PYA). “This is happening for rural health clinics. None of those individual physicians are going to have very many Part B charges, but when they aggregate everything ... all of a sudden you’re way above $30,000 for that group.”

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.